Chinopharma Ltd
34 IDL certificates：Been granted by NMPA from 2006 to 2017.
56 API products：Status "A" by Oct. of 2020.
41 API products：Status "I" by Oct. of 2020.
280 API products：To be filed.
52 products from India：Has been commercialized by end of 2018.
275 products： Exclusive agency agreements signed with over 100 pharmaceutical manufacturers.
+700 FDF customers：CSC has good business relationship in China market.
Over 50 million US dollars：CSC’s annual sales volume in 2018.
Over 3300 products &1000 companies：CSC built its own data base.